Abstract
A solid-phase enzyme immunoassay (EIA) with the capture antibody principle was developed and evaluated for detection of immunoglobulin M (IgM) specific for group B coxsackieviruses (CBV) in human serum. Of 19 patients who were culture positive for CBV type 4 infections, the EIA for CBV type 4 IgM was more sensitive (84%; 16/19 positive) than a standard microneutralization test (16%; 3/19 positive) and a microneutralization assay on the IgM fractions obtained by sucrose density gradient fractionation of human serum (68%; 13/19 positive). The attempt to produce a serotype-specific EIA was not successful, as IgM antibodies were detected to heterotypic CBV. The pooled CBV types 2 to 5 IgM EIA demonstrated an overall sensitivity of 88% (21/24 positive) in comparison to virus isolation for CBV types 4 and 5. The EIA was specific for IgM to CBV, with the exception of some cross-reactions with hepatitis A IgM-positive sera (15%; 3/20). In comparison to the microneutralization test, the EIA for pooled CBV IgM was more rapid, less cumbersome, and more sensitive. Commercially available reagents used in this study enable the CBV IgM EIA to be developed in diagnostic virology laboratories.
Publisher
American Society for Microbiology
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Enteroviruses and Parechoviruses;Principles and Practice of Pediatric Infectious Diseases;2023
2. Enteroviruses and Parechoviruses;Principles and Practice of Pediatric Infectious Diseases;2018
3. Enteroviruses and Parechoviruses;Principles and Practice of Pediatric Infectious Diseases;2012
4. ENTEROVIRUSES AND PARECHOVIRUSES;Feigin and Cherry's Textbook of Pediatric Infectious Diseases;2009
5. Enterovirus and Parechovirus Infections;Infectious Diseases of the Fetus and Newborn Infant;2006